Sign in
4

Changes in Ownership

Vanda Pharmaceuticals Inc. Filed Acc 0001209191-21-040240

Director acquired 5,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Mitchell Stephen Ray Director 2021-06-10 Grant or award +5,000 10,200 D: show line 1 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Mitchell Stephen Ray Director 2021-06-10 Grant or award · Stock Option (right to buy) +10,000 10,000 D: show line 2 in the form
Loading xslF345X03/doc4.xml…